IP Library Granted Patent US 10,974,166
Granted Patent B2
US 10,974,166 · App. 15/669,498 · Granted Apr 13, 2021

Protein having affinity for immunoglobulin, affinity separation agent and column for liquid chromatography using the same

Inventors: Shoya Yoda (Kanagawa, JP); Satoru Misawa (Kanagawa, JP); Risa Nakata (Kanagawa, JP)
Assignee: Mitsubishi Chemical Corporation
B01D15/08B01D15/3809B01J20/24B01J20/289B01J20/321B01J20/3204B01J20/3212B01J20/3219B01J20/3274C07K1/22C07K14/31C07K17/12C12N15/09G01N30/02C07K1/00C12N15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,974,166
App. No.
15/669,498
Granted
Apr 13, 2021
Kind
B2
Abstract

One embodiment of the present invention is a protein having affinity for an immunoglobulin, which is a protein having two or more domains derived from any of the amino acid sequences of E, D, and A domains of protein A, and in the amino acid sequence of at least one of the domains, one or more lysines are included, and the C-terminal lysine is deleted or substituted, or a protein having affinity for an immunoglobulin, which is a protein having two or more domains derived from any of B, C, and Z domains of protein A, and in the amino acid sequence of at least one of the domains, one or more lysines are included, and lysine at position 4 and the C-terminal lysine are deleted or substituted.

Claims (7)

1. A protein having affinity for an immunoglobulin, which is a protein comprising two or more domains derived from any of B, C, and Z domains of Protein A represented by SEQ ID NOS: 4 to 6, wherein the amino acid sequence of at least one domain of the two or more domains comprises one or more lysines, and when the C-terminal lysine of each domain and a sequence at positions 1 to 5 in the amino acid sequence of each domain are defined as a ligation site sequence, among the lysines in the amino acid sequence only the C-terminal lysine and lysine at position 4 in at least one of the ligation site sequences are deleted or substituted.

2. A protein having affinity for an immunoglobulin, which is a protein comprising two or more domains derived from any of B, C, and Z domains of Protein A represented by SEQ ID NOS: 4 to 6, wherein the amino acid sequence of at least one domain of the two or more domains comprises one or more lysines, and among the lysines in the amino acid sequence only the lysine at position 4 is deleted or substituted and the C-terminal lysine is substituted.

3. The protein according to claim 2 , wherein the lysine at position 4 is deleted.

4. The protein according to claim 2 , wherein at least one lysine of the lysine at position 4 and the C-terminal lysine is substituted with a hydrophilic amino acid.

5. A protein having affinity for an immunoglobulin, which is a protein comprising two or more domains derived from any of B, C, and Z domains of Protein A represented by SEQ ID NOS: 4 to 6, wherein the amino acid sequence of at least one domain of the two or more domains comprises one or more lysines, and among the lysines in the amino acid sequence only the lysine at position 4 is deleted and the C-terminal lysine is deleted or substituted.

6. The protein according to claim 5 , wherein the C-terminal lysine is deleted.

7. The protein according to claim 5 , wherein the C-terminal lysine is substituted with a hydrophilic amino acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2017
From: YODA, SHOYA; MISAWA, SATORU; NAKATA, RISA
To: MITSUBISHI CHEMICAL CORPORATION
Reel/Frame 043220/0022 →
Priority Claims (2)
JP JP2015-021577 · Feb 5, 2015 · national
JP JP2015-021578 · Feb 5, 2015 · national
Continuity (2)
Continuation PCTJP2016053116 · Feb 2, 2016
Related Publication 20170333811A1 · Nov 23, 2017